Aug 10, 2021 / 08:30PM GMT
Operator
(technical difficulty) ladies and gentlemen, and thank you for joining the Alpine Immune Sciences second-quarter 2021 financial results and corporate update conference call. Currently, all participants are in a listen-only mode. (Operator Instructions) As a reminder, this conference is being recorded Tuesday, August 10, 2021.
I would now like to introduce Alex Sharif, Director, Investor Relations and Corporate Development. Please go ahead.
Alex Sharif - Alpine Immune Sciences, Inc. - Director, IR & Corporate Development
Thank you, Mary. With me on today's call from Alpine Immune Sciences are Executive Chairman and CEO, Dr. Mitchell Gold; President and Head of Research and Development, Dr. Stanford Peng; Chief Financial Officer, Paul Rickey; and Chief Business Officer, Dr. Remy Durand.
This afternoon, Alpine Immune Sciences issued a press release announcing the company's second-quarter 2021 financial results and corporate update. If you have not received this news release and would like to read it or if you would simply like to be added to
Q2 2021 Alpine Immune Sciences Inc Earnings Call Transcript
Already have an account? Log in
Get the full story
Access to All Earning Calls and Stock Analysis | |
30-Year Financial on one screen | |
All-in-one Stock Screener with unlimited filters | |
Customizable Stock Dashboard | |
Real Time Insider Trading Transactions | |
8,000+ Institutional investors’ 13F holdings | |
Powerful Excel Add-in and Google sheets Add-on | |
All data downloadable | |
Quick customer support | |
And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent
4.6 out of 5 Trustpilot